Rite Aid Corporation Keeps Its Better Half: What’s It Mean For RAD Stock?

Rite Aid Corporation’s pro forma disclosure of what’s left after the Walgreens deal confirms our previous conclusion, that RAD stock is a no-brainer.

Posted in Healthcare & Biotech, Members, Mergers & Acquisitions | Tagged , , , | Leave a comment

Why Rite Aid Corporation (NYSE:RAD) Stock Is A No-Brainer At $2.23

Why RAD stock presents deep value and what we expect short and long-term from Rite Aid Corporation (NYSE:RAD).

Posted in Healthcare & Biotech, Retail | Tagged , , , | 1 Comment

The Outlook for Rite Aid Corporation (NYSE:RAD) Stock At $4 Has Not Changed!

There is a new sense of optimism for the Walgreens (WBA) Rite Aid Corporation (NYSE:RAD) merger. Fortunately, it does not matter for RAD stock owners.

Posted in Healthcare & Biotech, Members, Mergers & Acquisitions | Tagged , , , , | 1 Comment

Forget Walgreens, Why Rite Aid (NYSE:RAD) Stock Is A Buy At $3

We added 10,000 additional shares of RAD stock when it fell 15%. Here’s why Rte Aid Corporaion (NYSE:RAD) is now a good investment

Posted in Healthcare & Biotech, Members, Mergers & Acquisitions, Timely Analysis, Uncategorized | Tagged , , , | 1 Comment

The Real Reason Regulators Are Blocking Walgreens Rite Aid Merger (WBA) (RAD)

Regulators want to avoid another Dollar Tree Family Dollar debacle with the Walgreens Rite Aid merger. Would be best for RAD stock.

Posted in HADE Platform, Healthcare & Biotech, Members | Tagged , , , , , | 4 Comments

March Madness: How To Play RAD, BAC Stock, & The S&P 500 (SPY) After Big Loss

After March Madness caused turmoil for the S&P 500 (NYSEARCA:SPY), BAC stock, and RAD stock, I examine how to play 20 different stocks.

Posted in Members, Portfolio Strategy, Timely Analysis | Tagged , , , , | 2 Comments

With The Walgreens Rite Aid Merger Outcome Near, Is RAD Stock Worth Buying At $5?

RAD stock has fallen to $5 with the Walgreens Rite Aid merger decision just weeks away. Does this make Rite Aid Corporation (NYSE:RAD) a good investment?

Posted in Editor's Pick, Healthcare & Biotech, Members, Mergers & Acquisitions | Tagged , , , | Leave a comment